How to buy Histogen stock (HSTO)

Histogen is a biotechnology business based in the US. Histogen shares (HSTO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.03 – a decrease of 9.75% over the previous week. Histogen employs 7 staff and has a trailing 12-month revenue of around $19,000.

Our top picks for where to buy Histogen stock

Buy Histogen stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Histogen stock price (NASDAQ: HSTO)

Use our graph to track the performance of HSTO stocks over time.

Histogen shares at a glance

• Key figures

Information last updated 2024-12-26.

Latest market close	$0.03
52-week range	$0.02 - $0.55
50-day moving average more info button	$0.21
200-day moving average more info button	$0.26
Wall St. target price	$2.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-2.81

Is it a good time to buy Histogen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Histogen price performance over time

Historical closes compared with the close of $0.025 from 2024-12-24

1 week (2024-12-20)	-9.75%
1 month (2024-11-27)	25.00%
3 months (2024-09-27)	-88.10%
6 months (2024-06-27)	-91.67%

1 year (2023-12-27)	-91.94%
2 years (2022-12-27)	-96.85%
3 years (2021-12-27)	6.884
5 years (2019-12-27)	75.04

Histogen financials

Revenue TTM	$19,000
Gross profit TTM	$-1,252,000
Return on assets TTM	-53.81%
Return on equity TTM	-119.89%
Profit margin	0%
Book value	$1.27
Market Capitalization more info button	$85,435

TTM: trailing 12 months

Histogen share dividends

We're not expecting Histogen to pay a dividend over the next 12 months.

Have Histogen's shares ever split?

Histogen's shares were split on a 1:20 basis on 2 June 2022 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Histogen shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Histogen shares which in turn could have impacted Histogen's share price.

Histogen share price volatility

Over the last 12 months, Histogen's shares have ranged in value from as little as $0.02 up to $0.55. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Histogen's is 1.118. This would suggest that Histogen's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Histogen overview

Histogen Inc. , a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California. On April 18, 2024, Histogen Inc.

Frequently asked questions

null
What percentage of Histogen is owned by insiders?
Currently 2.853% of Histogen shares are held by insiders. How many people work for Histogen?
Latest data suggests 7 work at Histogen. When does the fiscal year end for Histogen?
Histogen's fiscal year ends in December. Where is Histogen based?
Histogen's address is: 10655 Sorrento Valley Road, San Diego, CA, United States, 92121 What is Histogen's ISIN number?
Histogen's international securities identification number is: US43358Y2028